GNF2133 is primarily utilized in the field of medical research, particularly in the study of cancer therapies. It functions as a potent inhibitor of specific enzymes that are involved in cell signaling pathways, which are often dysregulated in various types of cancer. By targeting these pathways, GNF2133 helps in understanding the mechanisms of tumor growth and progression, and it serves as a valuable tool in the development of targeted cancer treatments. Additionally, its application extends to preclinical studies where it is used to evaluate the efficacy and safety of new therapeutic strategies aimed at combating drug-resistant cancers.